ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes

Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with or without acute coronary syndromes (ACS) represent a subgroup with a challenging pharmacological management. Indeed, if on the one hand, antithrombotic therapy should reduce the risk related to recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Leonardo, Rubboli, Andrea, Lettino, Maddalena, Tubaro, Marco, Leonardi, Sergio, Casella, Gianni, Valente, Serafina, Rossini, Roberta, Sciahbasi, Alessandro, Natale, Enrico, Trambaiolo, Paolo, Navazio, Alessandro, Cipriani, Manlio, Corda, Marco, De Nardo, Alfredo, Francese, Giuseppina Maura, Napoletano, Cosimo, Tizzani, Emanuele, Nardi, Federico, Roncon, Loris, Caldarola, Pasquale, Riccio, Carmine, Gabrielli, Domenico, Oliva, Fabrizio, Massimo Gulizia, Michele, Colivicchi, Furio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Position Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155223/
https://www.ncbi.nlm.nih.gov/pubmed/35663586
http://dx.doi.org/10.1093/eurheartj/suac020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155223/
https://www.ncbi.nlm.nih.gov/pubmed/35663586
http://dx.doi.org/10.1093/eurheartj/suac020

Ejemplares similares